Press release
Insomnia Market size was valued at US$ 5.23 Bn in 2023 and the total revenue is expected to grow at 4.2 % through 2024 to 2030, reaching nearly US$ 6.97 Bn.
Insomnia Market
Insomnia Market Overview:
The global insomnia market is set to witness significant growth, with its market size valued at USD 5.23 billion in 2023. Projections indicate that the market will grow at a CAGR of 4.2% from 2024 to 2030, reaching an estimated USD 6.97 billion by the end of the forecast period.
Insomnia, a prevalent sleep disorder that affects individuals across various demographics, continues to challenge both the healthcare industry and the individuals suffering from it. This condition, characterized by difficulty falling or staying asleep, can occur independently or in conjunction with other psychological issues. Women are particularly more prone to insomnia, especially during critical life stages such as pregnancy, postpartum, and menopause. Despite extensive research, the precise cause of insomnia remains elusive.
Your Sample Report Is Just a Click Away! https://www.maximizemarketresearch.com/request-sample/37228/
Drivers in the Insomnia Market :
The insomnia market is primarily driven by the introduction of innovative sleep-inducing medications, devices, and treatments. Notable advancements include a groundbreaking treatment developed by the Insomnia Clinic in Bloomsbury, which has shown an 80% success rate in clinical trials. Additionally, Eisai Inc.'s development of lemborexant, a dual orexin receptor antagonist, promises effective treatment for insomnia, particularly among the elderly population. The affordability and efficacy of these devices and medications are expected to play a pivotal role in propelling market demand.
Insomnia Market Trends:
A significant trend reshaping the dry shampoo market is the growing awareness of hair health. Consumers are increasingly seeking products that allow for extended intervals between washes while maintaining hair's natural sebum. This trend is further amplified by the rising demand for products that are free from harsh chemicals, catering to those with sensitive scalps. The emphasis on eco-friendly practices, including reduced water usage, is also driving market growth, with consumers gravitating toward brands that prioritize sustainability.
๐๐๐๐ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง? ๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ + ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐๐ซ๐: https://www.maximizemarketresearch.com/inquiry-before-buying/37228/
Insomnia Market Opportunities:
Manufacturers in the insomnia market are increasingly adopting competitive pricing strategies to capture market share. Additionally, mergers, acquisitions, and technological innovations remain key focal points, positioning companies to capitalize on emerging opportunities in the market.
What is Insomnia Market Regional Insight?
North America is expected to dominate the global insomnia market throughout the forecast period, with the region accounting for the largest market share in 2023. The Asia Pacific region, excluding Japan, is also projected to experience substantial growth due to an increase in shift work and urbanization, leading to a rise in sleep disorders. Countries like Indonesia, India, and China are anticipated to drive this growth, with the United States and Canada significantly contributing to North America's market leadership. According to the Centers for Disease Control and Prevention (CDC), millions of adults in the U.S. suffer from insomnia, largely attributed to unhealthy lifestyles and rising stress levels.
Curious to peek inside? Grab your sample copy of this report now: https://www.maximizemarketresearch.com/request-sample/37228/ ๏ปฟ
Segmentation Analysis of the Insomnia Market
by Therapy
Cognitive Behavioral Therapy for Isomnia
Hypnotherapy
Other Alternative Therapies
by Drug
Class Antidepressants
Melatonin Antagonist
Benzodiazepines
Nonbenzodiazepines
Orexin Antagonist
Others
Who is the largest manufacturers of Insomnia Market worldwide?
1. Astellas
2. Biocodex S A
3. Consumer Healthcare Inc.
4. Dainippon Sumitomo
5. ECR Pharmaceuticals
6. Eisai Co.
7. Flynn Pharma
8. Johnson and Johnson
9. Meda Consumer Healthcare Inc.
10. Merck and Co. Inc.
11. Neurim
12. Pernix Therapeutics
13. Pfizer Inc
14. Purdue Pharma L.P.
15. Sanofi Pasteur
16. SkyePharma
17. Takeda Pharmaceutical Company
18. Mallinckrodt
19. Galt Pharmaceuticals, LLC.
Get Discount On The Purchase Of This Report @https://www.maximizemarketresearch.com/market-report/insomnia-market/37228/
Key Offerings:
Past Market Size and Competitive Landscape
Insomnia Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Insomnia Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
Explore our top-performing reports on the latest trends:
Global Shear Wrenches Market https://www.maximizemarketresearch.com/market-report/global-shear-wrenches-market/83349/
Global Electric Pruning Shears Market https://www.maximizemarketresearch.com/market-report/electric-pruning-shears-market/90980/
Global High Reliability Semiconductor Market https://www.maximizemarketresearch.com/market-report/high-reliability-semiconductor-market/115921/
South Korea Cleanroom Disposable Gloves Market https://www.maximizemarketresearch.com/market-report/south-korea-cleanroom-disposable-gloves-market/38283/
Global Sweet Biscuits Market https://www.maximizemarketresearch.com/market-report/global-sweet-biscuits-market/115151/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โ +91 9607365656
๐ sales@maximizemarketresearch.com
๐ www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market size was valued at US$ 5.23 Bn in 2023 and the total revenue is expected to grow at 4.2 % through 2024 to 2030, reaching nearly US$ 6.97 Bn. here
News-ID: 3617170 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR โฆ
According to a new report by Maximize Market Research, the global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032, growing at a CAGR of 6.13%. A major surge in biopharmaceutical R&D and oncology-focused studies is driving the global clinical trials market toward nearly USD 88.26 billion by 2032 at a 6.13% CAGR.
โบ Get a sample of theโฆ
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5 โฆ
Turbo Trainer Market size was valued at USD 281.52 Mn. in 2024 and the total Turbo Trainer revenue is expected to grow at 5.16% through 2025 to 2032, reaching nearly USD 421.03 Mn.
Turbo Trainer Market Overview:
The Turbo Trainer Market is witnessing significant growth as fitness enthusiasts increasingly adopt indoor cycling equipment for year-round training. Turbo trainers, which allow users to convert regular bicycles into stationary exercise machines, have become essentialโฆ
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of โฆ
Sodium Acetate Market size was valued at USD 206.17 Million in 2024, and the total revenue is expected to grow at CAGR of 7 % from 2025 to 2032, reaching nearly USD 354.24 Million.
Sodium Acetate Market Overview:
The Sodium Acetate Market is experiencing steady growth due to its widespread applications across industries such as food and beverage, pharmaceuticals, textiles, and chemical manufacturing. Sodium acetate, a versatile salt of acetic acid, isโฆ
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR - "India Tire โฆ
According to a new report by Maximize Market Research, the India tire market was valued at approximately USD 13.4 billion in 2024 and is expected to climb to USD 27.6 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.6 %. The growth is underpinned by increasing automotive production, growing replacement demand, and rising adoption of radial tyres.
โบ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/21022/
โฆ Key Highlights
Market sizeโฆ
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rateโฆ
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br โฆ
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on toโฆ
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomniaโฆ
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with dailyโฆ
Mattress Sydney โ Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioningโฆ
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimerโs disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseasesโฆ
